Clinical Research Firms purchased by Elligo Health

AUSTIN, TX, September 24, 2021 – Elligo Health Research has announced the acquisition of research practice management and clinical services firm ClinEdge in a $135 million transaction.  The acquisition also includes GuideStar Research and BTC of New Bedford.  The acquisition is expected to result in a large end-to-end healthcare-enabling research firm.

“This is another tremendous milestone in the evolution of GuideStar Research as a leading clinical trials research organization,” says Future Factory Managing Director Kristin Hutchins.  Ms. Hutchins, who served earlier as President and CEO of GuideStar Research, sees tremendous opportunity in the integration of these companies.  “The combination of each of these companies’ experience and skill sets will provide great opportunities to streamline the clinical research process from beginning to end and ultimately increase patient’s access to clinical trials.”

Kristin Hutchins is Honored for 25 Years at Future Factory

NEW ORLEANS, June 1, 2021 – Kristin Hutchins was recently honored for her 25 years in management of Future Factory portfolio companies.  During this time, Kristin has served in executive management roles in Future Factory’s invested firms, leveraging her expertise in healthcare and technology.  Kristin has worn many different hats from board member to chief executive officer. Ed Michael Reggie, Managing Director of Future Factory, praised Kristin for her leadership, strong managerial ability, and strategic thinking that has contributed to the successes of the portfolio companies.  “We depend on Kristin for her operational leadership, employee development skills, and her commitment to excellence.  She is held in the highest esteem by our team and within our invested companies.”  

Kristin began her career with Future Factory by rising through the ranks at American LIFECARE, the largest independent Preferred Provider Organization in the Gulf South region.  She ultimately became President where she was responsible for the entire operations of the company including network development and provider relations, marketing, claims, customer service, medical management, and information systems.  She led the team in negotiating the sale of American LIFECARE to Private Healthcare Systems, now part of MultiPlan (NYSE: MPLN).

Kristin later was appointed a board member representing Future Factory’s seed investment in a Seattle-based physician software company. In addition, she worked with Louisiana Fund One in screening life science companies and inventions for possible investment.  

Kristin served as President and Chief Executive Officer of GuideStar Research, a clinical trials management company focused on the development and management of clinical research programs for hospitals, academic medical centers, and physician practices. Ms. Hutchins led the efforts towards building a company that earned national recognition and credibility as a top service provider in the clinical research and health care industries. GuideStar was sold to ClinEdge, now an Elligo Health company.  

Most recently, Ms. Hutchins has been involved with applying her healthcare expertise towards the development of a consumer advocacy website for end-of- life services and the first comparison website for funeral homes in the US. Her skills have led to the creation of a preferred provider network that is credentialed with best practices honed by her healthcare experience. 

Scripps National Media profiles

CINCINATTI, OH, August 25, 2020 – Scripps National Media, one of the largest TV station groups with 55 network affiliates spread over the country, profiled in a lengthy story highlighted by an interview with the site’s founder and consumer advocate Ed Michael Reggie. In the midst of the coronavirus pandemic, Reggie shared important information about pricing funeral costs, observing social distancing guidelines and tips on choosing the right funeral home or crematory.

Funeralocity Founder Interviewed by THE CITY about the Impact of Coronavirus

NEW YORK, May 21, 2020 – New York publication THE CITY talked to founder Ed Michael Reggie about how the coronavirus outbreak has impacted the pricing of funeral services in the city. Unprecedented demand for funeral services in the New York City area has caused costs to soar. Prices for cremations, the most commonly requested service right now, have increased an average of 43%. Prices have also increased for traditional burials.

The New York City health department reported 32,000 fatalities from March 11 to May 2 — four times more deaths than the city’s normally expected figure. This unparalleled need for funeral services and the extra expense incurred by funeral homes in order to provide services safely has contributed to the increase in prices.

“No other region is indicating this kind of instability,” Reggie said. For grieving families, in addition to the higher cost, finding a funeral home that will take on a body can be a challenge. “In many instances, people are having to go to cemeteries outside of their immediate area, thus incurring additional transportation expenses,” he continued.